Page 131 - Merck Sharp News Today

Pembrolizumab and olaparib demonstrated antitumor activity and acceptable safety for men with prostate cancer.

Charging high prices on life-saving drugs, as Merck Sharp & Dohme has done, may weaken faith in the patent system as a whole

September marked Rizo's biggest spending month ever.

DiCeglie faces Democratic challenger Eunic Ortiz.

/PRNewswire/ -- Astellas Pharma Inc. (TSE:4503, President and CEO: Kenji Yasukawa, Ph.D., "Astellas") and Seagen Inc. (Nasdaq:SGEN) today announced that...

Merck known as MSD outside the United States and Canada, is commencing today, through a subsidiary, a cash tender offer to purchase all outstanding shares of common stock of Acceleron Pharma Inc. . On Sept. 30, 2021, Merck announced that it had entered into a definitive agreement to acquire Acceleron. Upon the successful closing of the tender offer, stockholders of Acceleron will receive $180 in cash for each share ...

Cue Biopharma - Consensus Indicates Potential 126.8% Upside

New Zealand is amongst the first countries in the world to sign an advanced purchase agreement for the new COVID-19 oral antiviral treatment molnupiravir from pharmaceutical company Merck Sharp & Dohme (MSD), Prime Minister Jacinda Ardern announced today

Auckland restrictions remain unchanged for another week as Government takes big steps with mandatory Covid vaccinations for many education and health sector workers.

His lone opponent has dropped out of the race.